Author

Eric A. Smith

University of UtahORCID 0000-0002-7510-5603Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:zebrafish· 1

Frequent Co-Authors

Anastasia Prokofyeva· 2 shared Dekker C. DeaconiD· 2 shared Robert L. Judson‐TorresiD· 2 shared Allie H. GrossmanniD· 1 shared Amanda JiangiD· 1 shared Carly A. BeckeriD· 1 shared Carly Becker· 1 shared David Henry LumiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anastasia Prokofyeva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment

Eric A. Smith, R. L. Belote, Nelly M. Cruz, Tarek E. Moustafa, Carly A. Becker, Amanda Jiang, Shukran Alizada, Anastasia Prokofyeva, Tsz Yin Chan, Tori A. Seasor, Michael A. Balatico, Emilio Cortes-Sanchez, David Henry Lum, John Robert Hyngstrom, Hanlin Zeng, , Robert L. Judson‐Torres

This study shows that dual FGFR/VEGFR inhibition causes regression of acral melanoma by targeting the tumor microenvironment rather than directly killing cancer cells.

Journal of Experimental & Clinical Cancer Research · Dec 3, 2024Peer-reviewedCancer Biology

Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi

Tanya Chhibber, Michael T. Scherzer, Anastasia Prokofyeva, Carly Becker, Rebecca G. Zitnay, Eric A. Smith, Nitish Khurana, Mikhail Skliar, Dekker C. Deacon, Matthew W. VanBrocklin, Hamidreza Ghandehari, Robert L. Judson‐Torres, Paris Jafari

This study develops UCL-211, a transdermal delivery system for miR211-5p, which stabilizes BRAFV600E+ melanocytic nevi by maintaining them in a growth-arrested state.

Journal of Controlled Release · Oct 21, 2024Peer-reviewedPharmacology & Toxicology